Albeit Pharmaceuticals Private Limited

Albeit Pharmaceuticals Private Limited - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24290MH2020PTC341392 Incorporated 03 July 2020 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company chemicals
Data last updated
Revenue · FY 2025
₹49.89 Lakh
Latest filing
Net loss · FY 2025
₹3.21 Lakh
Net margin -6.4%
EBITDA · FY 2025
-₹1.15 Lakh
EBITDA margin -2.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Albeit Pharmaceuticals Private Limited

Data last updated:

Albeit Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 03 July 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PTC341392.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Lalita and Manokamini Verma.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 983 Lotus Colony Govandi Behind Kokan Bank, Mumbai, Maharashtra, India – 400088.

As per the financials filed for FY 2025, the company reported a revenue of ₹49.89 Lakh. For the same year it recorded a net loss of ₹3.21 Lakh (net margin -6.4%) and EBITDA of -₹1.15 Lakh (EBITDA margin -2.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.

Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.

Company Details of Albeit Pharmaceuticals Private Limited
CIN U24290MH2020PTC341392
Registration Number 341392
Incorporation Date 03 July 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    983 Lotus Colony Govandi Behind Kokan Bank, Mumbai, Maharashtra, India – 400088
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Albeit Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Albeit Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Albeit Pharmaceuticals Private Limited in one report.

Financials from FY 2021 Directors & ownership Charges & compliance

Business Activity of Albeit Pharmaceuticals Private Limited

The main business activity of Albeit Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
QHuman health and social work activities86Human health activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Albeit Pharmaceuticals Private Limited FY 2025 filings available

Albeit Pharmaceuticals Private Limited reported revenue of ₹49.89 Lakh for FY 2025.

Revenue · FY 2025
₹49.89 Lakh
Net loss · FY 2025
₹3.21 Lakh margin -6.4%
EBITDA · FY 2025
-₹1.15 Lakh margin -2.3%

Compounded Annual Growth Rate (CAGR) of Albeit Pharmaceuticals Private Limited

Revenue CAGR growth
3 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 75%
3 years · compounded
▼ 55%

Revenue has grown at a compounded annual rate (CAGR) of 13% over three years. EBITDA rose 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Albeit Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA-₹1.15 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹3.21 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Albeit Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-2.3%••••••••••••••••
Net Profit Margin-6.4%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Albeit Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2021

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Albeit Pharmaceuticals Private Limited

Albeit Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Jayin Pharmaceuticals Private Limited₹50.19 Lakh (FY 2025)••••••••23.0%••••Lucknow, Uttar Pradesh, India
Arsenal Pharmaceuticals Private Limited₹50.16 Lakh (FY 2025)••••••••-36.0%••••Guwahati, Assam, India
Lorica Pharmaceuticals Limited₹50.09 Lakh (FY 2025)••••••••-13.0%••••Badaun, Uttar Pradesh, India
Grenitta Pharmaceuticals Private Limited₹50.08 Lakh (FY 2025)••••••••••••Jaipur, Rajasthan, India
Liaise Pharmaceuticals Private Limited₹50.08 Lakh (FY 2024)••••••••70.0%••••Gotri, Gujarat, India
Albeit Pharmaceuticals Private Limited this company₹49.89 Lakh (FY 2025)••••••••••••Mumbai, Maharashtra, India
Weizman Pharmaceuticals Private Limited₹49.87 Lakh (FY 2025)••••••••5.0%••••Bahraich, Uttar Pradesh, India
Curenetic Pharmaceuticals Private Limited₹49.82 Lakh (FY 2025)••••••••8.0%••••Noida, Uttar Pradesh, India
Xenomics Pharmaceuticals Private Limited₹49.71 Lakh (FY 2024)••••••••53.0%••••Hyderabad, Telangana, India
Vancorp Pharmaceuticals Private Limited₹49.64 Lakh (FY 2025)••••••••3.0%••••Gautam Budh Nagar, Uttar Pradesh, India
Reinheit Pharmaceuticals Private Limited₹49.48 Lakh (FY 2024)••••••••132.0%••••Kolkata, West Bengal, India

Peers are the five companies nearest above and the five nearest below Albeit Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Board of Directors of Albeit Pharmaceuticals Private Limited

Albeit Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
LalitaDirector03 Jul 20206 Years 3 MonthsCurrent
Manokamini VermaDirector27 Aug 20251 Years 1 MonthsCurrent

Charges & Borrowings of Albeit Pharmaceuticals Private Limited

Albeit Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Albeit Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Albeit Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Albeit Pharmaceuticals Private Limited

Albeit Pharmaceuticals Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Harish Kumar ceased to be Director on 28 Aug 2025.

AGM
Albeit Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Harish Kumar ceased to be Director.
Ceased
Sunil Kumar Verma ceased to be Director.
Appointed
Manokamini Verma was appointed as Director.
Filing
Albeit Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Harish Kumar was appointed as Director.
Appointed
Lalita was appointed as Director.
Appointed
Sunil Kumar Verma was appointed as Director.
Incorporation
03 Jul 2020
Albeit Pharmaceuticals Private Limited was registered on 03 Jul 2020 with Roc Mumbai I & aged 6 years 3 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Albeit Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Albeit Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Albeit Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Albeit Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Albeit Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Albeit Pharmaceuticals Private Limited

Albeit Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 03 July 2020 (6+ years old) and is registered under CIN U24290MH2020PTC341392.

Albeit Pharmaceuticals reported revenue of ₹49.89 Lakh for FY 2025.

Albeit Pharmaceuticals has 2 current directors:

Albeit Pharmaceuticals reported a net loss of ₹3.21 Lakh (net margin -6.4%) and EBITDA of -₹1.15 Lakh (EBITDA margin -2.3%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Albeit Pharmaceuticals is 13% over three years. CAGR is the steady yearly rate that links the first and the last year.

The CIN (Corporate Identification Number) of Albeit Pharmaceuticals is U24290MH2020PTC341392. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Albeit Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.

Albeit Pharmaceuticals was incorporated on 03 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Albeit Pharmaceuticals by revenue are Jayin Pharmaceuticals Private Limited, Arsenal Pharmaceuticals Private Limited, Lorica Pharmaceuticals Limited, Grenitta Pharmaceuticals Private Limited, Liaise Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Harish Kumar ceased to be Director on 28 Aug 2025. Sunil Kumar Verma ceased to be Director on 28 Aug 2025. Manokamini Verma was appointed as Director on 27 Aug 2025. Albeit Pharmaceuticals has 6 board changes on record in total.

The registered office of Albeit Pharmaceuticals is at 983 Lotus Colony Govandi Behind Kokan Bank, Mumbai, Maharashtra, India – 400088.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available